Home / Guides / Generic liraglutide
Real generics. One shot a day.
Is there a generic Saxenda? Yes. Generic liraglutide, explained
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
NexLife publishes this guide and offers compounded semaglutide and tirzepatide, which aren’t generics. It doesn’t offer liraglutide. No company named here reviewed or endorsed this guide.
Yes: as of November 1, 2026, the FDA lists three approved generics of Saxenda (liraglutide) for weight loss and eight of Victoza for type 2 diabetes. NexLife doesn’t offer liraglutide: compounded semaglutide, a weekly shot that isn’t a generic or FDA-approved, is $119 a month on its 12-month plan, or $139 month to month.
- Generic Saxenda: three FDA-approved, for weight loss
- Generic Victoza: eight FDA-approved, for type 2 diabetes
- Liraglutide: one shot a day; Wegovy and Zepbound, one a week
$119/mo on a 12-month plan, all-inclusive, same price at every dose
Or $139/mo month to month
A weekly shot: not liraglutide, and not a generic
About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
See all 4 plans and what a year costs
| Plan | Per month | 12 months at this rate |
|---|---|---|
| 12-month Lowest monthly price | $119 | $1,428 |
| 6-month | $125 | $1,500 |
| 3-month | $132 | $1,584 |
| Month to month | $139 | $1,668 |
Month to month costs $240 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.
Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works
4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.
- Licensed U.S. providers
- LegitScript certified
- Free expedited shipping
- HSA, FSA, Affirm, Klarna, Afterpay
- 24/7 support, real people
- Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)
Compounded semaglutide and tirzepatide aren’t FDA-approved, aren’t generics and aren’t liraglutide. A licensed provider prescribes them only when they offer a significant difference for you.
At a glance
What should you know?
| Question | Answer |
|---|---|
| Generic Saxenda? | Yes: three, approved for weight loss. Teva’s came first (August 27, 2025), then Biocon’s and Orbicular’s (February 24, 2026) |
| Generic Victoza? | Yes: eight, for type 2 diabetes, not weight loss. Hikma’s came first, on December 23, 2024 |
| How do you take it? | One shot a day, at any time, with or without meals. Wegovy and Zepbound are once a week |
| What does it cost? | We couldn’t verify a cash price for the generics. Brand Saxenda’s list price is $1,349.02 for a 5-pen box, before insurance or discounts |
| Generic Wegovy or Zepbound? | No. Semaglutide and tirzepatide have no FDA-approved generics yet |
| Does NexLife offer it? | No. Compounded semaglutide at NexLife is a weekly shot, not FDA-approved and not one of these generics: $119 a month on the 12-month plan |
From Drugs@FDA, the labels and Novo Nordisk, checked November 1, 2026.
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Generic liraglutide is FDA-approved. As of November 1, 2026, the FDA lists three generics of Saxenda and eight of Victoza.
- Three are for weight loss: Saxenda generics from Teva (approved August 27, 2025), Biocon and Orbicular (February 24, 2026).
- Victoza’s eight are for type 2 diabetes, not weight loss. Hikma’s came first, on December 23, 2024.
- It’s a daily shot. Wegovy and Zepbound are weekly, and no semaglutide or tirzepatide generics are FDA-approved yet.
- Saxenda itself is ending, with last shipments to wholesalers in late January 2027. We couldn’t verify a cash price for the generics.
- NexLife doesn’t offer liraglutide. Compounded semaglutide at NexLife, a weekly shot that isn’t FDA-approved, is $119 a month on the 12-month plan.
FDA approvals
Which generic liraglutide products has the FDA approved?
Eleven, as of November 1, 2026: three generics of Saxenda and eight of Victoza.
| Company | Generic of | FDA approval | Application |
|---|---|---|---|
| Hikmathe first generic Victoza | Victoza, for type 2 diabetes | December 23, 2024 | ANDA 215503 |
| Emerge Biosciencesold by Meitheal and NorthStar Rx | Victoza, for type 2 diabetes | April 2, 2025 | ANDA 218115 |
| Lupin | Victoza, for type 2 diabetes | July 22, 2025 | ANDA 215421 |
| Tevathe first generic Saxenda | Saxenda, for weight loss | August 27, 2025 | ANDA 214568 |
| Orbicularalso sold by Cipla | Victoza, for type 2 diabetes | January 14, 2026 | ANDA 217590 |
| Biocon | Saxenda, for weight loss | February 24, 2026 | ANDA 217063 |
| Orbicularalso sold by Cipla | Saxenda, for weight loss | February 24, 2026 | ANDA 217234 |
| Biocon | Victoza, for type 2 diabetes | March 11, 2026 | ANDA 215245 |
| Fresenius Kabi | Victoza, for type 2 diabetes | March 30, 2026 | ANDA 212552 |
| Mylan Institutional | Victoza, for type 2 diabetes | June 15, 2026 | ANDA 213155 |
| Sandoz | Victoza, for type 2 diabetes | July 1, 2026 | ANDA 212972 |
Swipe the table sideways to see every column.
From each application’s page on Drugs@FDA, checked November 1, 2026, listed by approval date. The FDA rates Saxenda’s generics as equivalent to Saxenda (code AP2) and Victoza’s to Victoza (AP1). Who sells each one comes from the labels on DailyMed.
The first generic Saxenda is Teva’s. The FDA approved it on August 27, 2025, and Teva announced its U.S. launch the next day, calling it “the first ever generic
The first generic Victoza is Hikma’s, the FDA said when it approved it on December 23, 2024, for blood sugar control in adults and children 10 and older with type 2 diabetes (the FDA’s announcement).
One more, without the brand name. Since June 24, 2024, Teva has also sold liraglutide made by Novo Nordisk under Victoza’s own approval, which DailyMed lists as an “NDA authorized generic”.
Approved isn’t always on the shelf. In the FDA’s words, “Approved drugs are not always available on or after the listed approval date.” We found labels on DailyMed for every maker above except Fresenius Kabi, Mylan Institutional and Sandoz.
Saxenda itself is ending. Novo Nordisk says it’s discontinuing Saxenda in the U.S., with last shipments to wholesalers in late January 2027. It says the decision “is not the result of any safety or quality-related concerns” (Novo Nordisk). The generics are separate products, from other makers.
Saxenda vs. Victoza
Generic Saxenda or generic Victoza: what’s the difference?
Both are liraglutide in the same 18 mg pen. They’re approved for different people, at different doses.
| Generic Saxenda (and Saxenda) | Generic Victoza (and Victoza) | |
|---|---|---|
| Approved for | Weight loss and keeping it off: adults with obesity, or overweight with a weight-related condition, and children 12 and older who weigh more than 60 kg (132 lb) and have obesity | Blood sugar control in type 2 diabetes, from age 10. Victoza and some of its generics also lower the risk of heart attack, stroke and heart-related death in adults with type 2 diabetes and heart disease |
| Daily doselabel | 0.6 mg the first week, then up 0.6 mg each week: 3 mg a day from week 5 | 0.6 mg the first week, then 1.2 mg; up to 1.8 mg a day if needed |
| The pen18 mg in 3 mL | Doses of 0.6 to 3 mg. At 3 mg a day, one pen lasts 6 days | Doses of 0.6, 1.2 or 1.8 mg. At 1.8 mg a day, one pen lasts 10 days |
| Box sizesbrand | 3 or 5 pens | 2 or 3 pens |
| Approved for weight loss? | Yes | No |
| FDA ratingDrugs@FDA | AP2: equivalent to Saxenda | AP1: equivalent to Victoza |
Swipe the table sideways to see every column.
From the Saxenda label (revised June 2026), the Victoza label (revised October 2025; read October 31, 2026), the generics’ labels on DailyMed and Drugs@FDA, checked November 1, 2026. How long a pen lasts is our arithmetic: 18 mg divided by the daily dose.
Same molecule, different jobs. The FDA rates each generic as equivalent to its own brand only: Saxenda’s generics to Saxenda, Victoza’s to Victoza. Victoza’s generics aren’t approved for weight loss.
The 16-week check. For adults, Saxenda’s label says to stop if you haven’t lost at least 4% of your starting weight after 16 weeks. A lasting, meaningful loss is unlikely from there.
Daily vs. weekly
How does daily liraglutide compare with weekly Wegovy and Zepbound?
Liraglutide is a once-a-day shot that lasts hours in the body, not days. Wegovy (semaglutide) and Zepbound (tirzepatide) are once a week. Here’s each from its label.
| Liraglutide (Saxenda and its generics) | Semaglutide (Wegovy shot) | Tirzepatide (Zepbound) | |
|---|---|---|---|
| How often | Once a day, at any time, with or without meals | Once a week, the same day each week, with or without meals | Once a week |
| Half-lifelabel | About 13 hours | About 1 week | About 5 days |
| Shots a yearat a steady dose | 365 | 52 | 52 |
| Starting dose | 0.6 mg a day for 1 week | 0.25 mg a week for 4 weeks | 2.5 mg a week for 4 weeks |
| Full dose | 3 mg a day, from week 5 | Usually 2.4 mg a week, after 4-week steps | 5, 10 or 15 mg a week, after 4-week steps |
| Approved for weight loss in | Adults, and children 12 and older over 60 kg with obesity | Adults, and children 12 and older with obesity | Adults only |
| Other approved uses | None for Saxenda; Victoza’s generics treat type 2 diabetes | Lowering heart attack and stroke risk in adults with heart disease and excess weight; a liver disease, MASH, with moderate to advanced scarring (not cirrhosis) | Moderate to severe obstructive sleep apnea in adults with obesity |
| FDA-approved genericchecked November 1, 2026 | Yes: 3 of Saxenda, 8 of Victoza | No | No |
| Boxed warning | Thyroid C-cell tumors in rodents | Thyroid C-cell tumors in rodents | Thyroid C-cell tumors in rodents |
Swipe the table sideways to see every column.
From the Saxenda (June 2026), Wegovy (June 2026) and Zepbound (August 2026) labels, checked November 1, 2026. Shots a year is our arithmetic.
What the trials found: not head to head
| Saxenda, 3 mg a day | Wegovy, 2.4 mg a week | Zepbound, 15 mg a week | |
|---|---|---|---|
| Trialas its label reports it | SCALE Obesity and Prediabetes (2015): label Study 1 | STEP 1 (2021): label Study 2 | SURMOUNT-1 (2022): label Study 1 |
| Who took partadults with obesity, or overweight with a related condition | 3,731 adults; no type 2 diabetes | 1,961 adults; no type 2 diabetes | 2,539 adults; no type 2 diabetes |
| Length | 56 weeks | 68 weeks | 72 weeks |
| Average weight lossvs. placebo | 7.4% placebo 3.0% | 14.9% placebo 2.4% | 20.9% placebo 3.1% |
| Lost 5% or more | 62.3% (34.4% on placebo) | 83.5% (31.1% on placebo) | 90.9% (34.5% on placebo) |
| Nauseapooled trials, label | 39.3% (13.8% on placebo) | 44% (16% on placebo) | 28% (8% on placebo) |
Swipe the table sideways to see every column.
Separate trials of different lengths, not head to head, each as its label reports it. These trials studied FDA-approved Saxenda, Wegovy and Zepbound; compounded semaglutide and tirzepatide weren’t studied.
Read it with care. None of these trials compared the medicines with each other. Generic Saxenda’s label reports the same trials as Saxenda’s.
Side effects are alike: mostly nausea, diarrhea, vomiting and constipation. In Saxenda’s trials, 9.8% stopped because of side effects, vs. 4.3% on placebo.
More on the weekly medicines: tirzepatide vs. semaglutide.
Cost
What does generic liraglutide cost?
We couldn’t verify a cash price for any of the liraglutide generics on October 31, 2026. Teva’s launch release lists none, and the pharmacy price pages we tried didn’t open for us. Rather than guess, here’s what the makers do publish, and what weekly shots cost.
| Option | Price | Good to know |
|---|---|---|
| Generic SaxendaTeva, Biocon, Orbicular | No verified price | Teva’s launch release lists no price, and pharmacy cash prices vary |
| Generic Victozaeight makers | No verified price | For type 2 diabetes; Medicare.gov says Part D plans should cover |
| Saxenda, brandNovo Nordisk’s list price | $1,349.02 a 5-pen box | The price before insurance or discounts, which Novo says most insured people don’t pay. At 3 mg a day, 5 pens last 30 days |
| Saxenda savings offerNovo Nordisk, if eligible | As little as $25 | Or up to $200 off each Saxenda prescription, for up to 12 months, Novo says |
| Wegovy shotself-pay, Novo Nordisk | $349 a month | $199 for each of a new patient’s first two fills at 0.25 or 0.5 mg, through December 31, 2026; $399 for Wegovy HD 7.2 mg |
| Wegovy pillself-pay, Novo Nordisk | $149 to $299 a month | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 or 25 mg |
| Zepboundself-pay, LillyDirect | $299 to $699 a month | $299 at 2.5 mg, $399 at 5 mg; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699 |
| Medicare | $50 a month | Covers Wegovy, Foundayo and the Zepbound KwikPen through December 31, 2027, not liraglutide |
Swipe the table sideways to see every column.
Liraglutide first, then the weekly medicines. Novo Nordisk’s list price and offer from novopricing.com and NovoCare, and Medicare’s rules from Medicare.gov, checked November 1, 2026. Self-pay prices from wegovy.com and LillyDirect, checked November 1, 2026; a Zepbound month is 28 days.
What sets your price: your plan’s drug list, the pharmacy, the box size and your dose. During the first weeks’ lower doses, each pen lasts longer than 6 days.
With Medicare: the
Who it fits
Who is generic liraglutide a good fit for?
Your provider decides, after reviewing your health and your other medicines. These label facts usually shape the choice.
If you’re 12 to 17
Generic Saxenda is approved from age 12 for teens who weigh more than 60 kg (132 lb) and have obesity. Wegovy is approved from 12 too; Zepbound only for adults.
If a daily routine suits you
It’s one shot a day, at any time, with or without meals. Miss more than 3 days, and the label restarts you at 0.6 mg.
If daily shots are the problem
Wegovy and Zepbound are weekly. Daily pills exist too: the Wegovy pill and Foundayo. Pills vs. shots.
If you have type 2 diabetes
Generic Victoza is approved for blood sugar control from age 10. Saxenda’s label says its safety and effectiveness in children with type 2 diabetes haven’t been established.
Who shouldn’t take it
Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or a serious allergy to liraglutide. It isn’t recommended with severe gastroparesis.
If you’re pregnant or planning to be
Saxenda’s label says it may cause fetal harm, and to stop it when a pregnancy is recognized. Tell your provider if you’re planning one.
Taking Saxenda now? Its last shipments to wholesalers are in late January 2027. Your provider can move you to a generic or another medicine.
Switching
Can you switch from liraglutide to semaglutide or tirzepatide?
Yes, with your provider. It’s a new prescription with its own starting dose, and the labels advise against taking two
Your provider sets the timing
They look at why you’re switching, how liraglutide has gone and your other medicines. Then they decide when to stop it and when to start the new one.
Taking two at once isn’t recommended
The Saxenda, Wegovy and Zepbound labels each say combining their medicine with another
GLP-1 isn’t recommended.Expect to start low
Wegovy starts at 0.25 mg a week and Zepbound at 2.5 mg a week, each for 4 weeks, then steps up. Your provider sets your own plan.
Plan for birth control pills
On tirzepatide, the Zepbound label says to switch to a non-oral method or add a barrier method. Do this for 4 weeks after starting and after each dose increase.
Moving to compounded semaglutide or tirzepatide through NexLife? Tell us what you take now in the online assessment. A licensed provider reviews it and decides whether, and how, to start you.
More on moving between
Compounded
Is compounded semaglutide or tirzepatide a generic?
No. Generic liraglutide is FDA-approved; compounded semaglutide and tirzepatide aren’t, and they aren’t generics. The FDA answers the question directly:
“No. A generic drug is approved by FDA under 505(j) of the FD&C Act and meets all of the requirements of that section (including establishing therapeutic equivalence to a brand name drug, among others), while a compounded drug is not approved by FDA.”
| Generic liraglutide | Compounded semaglutide or tirzepatide | |
|---|---|---|
| FDA approval | Approved before it’s sold | Not FDA-approved |
| Compared with the brand | Must establish therapeutic equivalence to its brand | No such review: the FDA doesn’t verify its safety, effectiveness or quality before it’s sold |
| Who makes it | A drug company, under its FDA approval | A state-licensed pharmacy, for one patient’s prescription |
| When it’s prescribed | For the uses on its label | Only when a licensed provider finds it offers a significant difference for you |
Swipe the table sideways to see every column.
From the FDA’s compounding questions and answers (content current as of September 16, 2025), read November 1, 2026.
The word matters. A compounded drug isn’t a generic of anything, and no generic semaglutide or tirzepatide is FDA-approved yet. Liraglutide is the
More: what compounded semaglutide is and compounded vs. brand-name semaglutide.
At NexLife
NexLife doesn’t offer liraglutide. Here’s what it does offer
Compounded semaglutide and tirzepatide, weekly shots that aren’t generics and aren’t FDA-approved. A licensed provider prescribes one only when it offers a significant difference for you.
| Compounded semaglutide | $119 a month on the 12-month plan, $125 on 6 months, $132 on 3 months or $139 month to month |
|---|---|
| Compounded tirzepatide | $139 a month on the 12-month plan, $149 on 6 months, $159 on 3 months or $169 month to month |
| Same at every dose | No membership fee, and nothing extra when your dose goes up. |
| Included | A licensed provider who follows your dose, the medication, a nutrition plan, a 1:1 coaching call, free expedited shipping and real people 24/7. |
| Who fills it | Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA), state-licensed 503A partner pharmacies. Questions come to us, not the pharmacy. |
| Ways to pay | Affirm, Klarna or Afterpay at checkout, or an HSA or FSA card; NexLife provides a letter of medical necessity. With Medicare, you can pay for yourself. |
| Price Match Guarantee† | Paying less for compounded semaglutide or tirzepatide with another licensed provider? We match your regular monthly price, with a receipt from the last 60 days. It doesn’t cover liraglutide or other brand-name or generic medicines. |
| Not prescribed? | No charge for medication. |
Against the market: month to month, $139 for compounded semaglutide is $60 under the $199 median of the 17 semaglutide programs in our
Who’s behind it: NexLife’s medical director is Adam Kennah, MD, board-certified in emergency medicine (ABEM). Call or text
Two medications.
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Generic liraglutide: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Is there a generic Saxenda?
Yes: as of November 1, 2026, the FDA lists three approved generics of Saxenda (liraglutide) for weight loss, from Teva, Biocon and Orbicular, and eight of Victoza, for type 2 diabetes. Teva’s was first: approved August 27, 2025, and launched the next day. Biocon’s and Orbicular’s followed on February 24, 2026.
Is there a generic Victoza?
Yes. The FDA lists eight, all for type 2 diabetes: Hikma’s was approved first, on December 23, 2024, then Emerge Bioscience, Lupin, Orbicular, Biocon, Fresenius Kabi, Mylan Institutional and Sandoz, through July 1, 2026. Teva also sells an authorized generic, made by Novo Nordisk under Victoza’s own approval. None is approved for weight loss.
How much does generic liraglutide cost?
We couldn’t verify a cash price on November 1, 2026: Teva’s launch release lists none, and the pharmacy price pages we tried didn’t open for us. For reference, Novo Nordisk’s list price for brand Saxenda is $1,349.02 for a 5-pen box, 30 days at the full dose, before insurance or discounts.
Is generic Victoza the same as Saxenda?
No. Both contain liraglutide in an 18 mg pen, but they’re approved for different uses at different doses: Saxenda and its generics for weight loss, at 3 mg a day, and Victoza and its generics for type 2 diabetes, at up to 1.8 mg. The FDA rates each generic against its own brand.
Is liraglutide a daily shot?
Yes. Liraglutide is injected once a day, at any time, with or without meals; its half-life is about 13 hours, its label says. Wegovy (semaglutide) and Zepbound (tirzepatide) are injected once a week. Miss more than 3 days of liraglutide, and the label restarts it at 0.6 mg.
Does insurance or Medicare cover generic liraglutide?
It depends on your plan’s drug list. Medicare’s
Can I switch from liraglutide to semaglutide or tirzepatide?
Yes, with your provider, who decides when to stop liraglutide and what dose to start. The labels say combining two
Is there a generic Wegovy or Zepbound?
Not that the FDA lists. Neither semaglutide (Wegovy, Ozempic) nor tirzepatide (Zepbound, Mounjaro) is on its 2026 list of first generic approvals, which runs through August 31 (checked November 1, 2026). Liraglutide is the weight-loss
Is compounded semaglutide a generic?
No. A generic is FDA-approved and must establish therapeutic equivalence to its brand, the FDA says, while a compounded drug isn’t FDA-approved. Compounded semaglutide and tirzepatide are prepared by a state-licensed pharmacy for one patient’s prescription. NexLife doesn’t offer liraglutide, brand or generic.
Is liraglutide as effective as semaglutide?
In separate trials, people lost more weight on weekly semaglutide. Saxenda 3 mg averaged 7.4% at 56 weeks in SCALE Obesity and Prediabetes (2015; 3.0% on placebo), and Wegovy 2.4 mg 14.9% at 68 weeks in STEP 1 (2021; 2.4%), their labels say. These trials studied FDA-approved Saxenda and Wegovy; compounded semaglutide wasn’t studied.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and checked this page
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
The FDA’s approval records, the labels (Victoza’s read October 31, 2026), Novo Nordisk’s notices and Medicare’s rules checked November 1, 2026.
- How we checked. The approvals come from Drugs@FDA, the FDA’s own database: each generic application’s page, with its approval date and equivalence rating, read on November 1, 2026. Approved uses come from the labels on DailyMed and the makers’ sites, and the first approvals from the FDA’s announcement and Teva’s release. Novo Nordisk’s discontinuation notice, list price and savings offer, Medicare.gov and the FDA’s compounding questions and answers were read the same day. Self-pay prices for Wegovy and Zepbound come from Novo Nordisk and LillyDirect, checked November 1, 2026. We don’t estimate prices we couldn’t verify, and we don’t treat separate trials as head to head.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
You know where generic liraglutide stands. Here’s a weekly option.
Start online in about 3 minutes, and a licensed provider decides if a compounded weekly shot is right for you: semaglutide at $119 a month on the 12-month plan, or tirzepatide at $139, at every dose.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, or by secure video where your state requires a live visit. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- FDA, Drugs@FDA: Saxenda (NDA 206321) and its therapeutic equivalents. Read November 1, 2026.
- FDA, Drugs@FDA: Teva’s liraglutide (ANDA 214568), approved August 27, 2025. Read November 1, 2026.
- FDA, Drugs@FDA: Hikma’s liraglutide (ANDA 215503) and Victoza’s therapeutic equivalents. Read November 1, 2026; each other application’s page is linked in the approvals table.
- FDA: FDA approves first generic of once-daily
GLP-1 injection to lower blood sugar in patients with type 2 diabetes (December 2024). Read November 1, 2026. - FDA: First generic drug approvals (the 2026 list, through August 31). Checked November 1, 2026.
- Teva: FDA approval and launch of generic Saxenda (liraglutide injection), August 28, 2025. Read October 31, 2026.
- DailyMed: liraglutide injection, Teva Pharmaceuticals (ANDA 214568), the generic of Saxenda. Read November 1, 2026.
- DailyMed: liraglutide injection, Hikma (ANDA 215503), the generic of Victoza. Read November 1, 2026.
- DailyMed: liraglutide injection, Biocon (ANDA 215245), with the cardiovascular indication. Read November 1, 2026.
- DailyMed: liraglutide injection, Teva Pharmaceuticals USA, NDA authorized generic of Victoza. Read November 1, 2026.
- Saxenda (liraglutide) prescribing information, Novo Nordisk, revised June 2026 (DailyMed). Read November 1, 2026.
- Victoza (liraglutide) prescribing information, Novo Nordisk, revised October 2025. Read October 31, 2026.
- Wegovy (semaglutide) prescribing information, Novo Nordisk, revised June 2026. Read November 1, 2026.
- Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026. Read November 1, 2026.
- Zepbound prescribing information, the FDA’s copy of the February 2026 revision (dosing and indications). Read November 1, 2026.
- The New England Journal of Medicine: A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE Obesity and Prediabetes), 2015. For the trial’s name and year; the figures on this page come from the Saxenda label.
- The New England Journal of Medicine: Once-weekly semaglutide in adults with overweight or obesity (STEP 1), 2021. For the trial’s name and year; the figures on this page come from the Wegovy label.
- The New England Journal of Medicine: Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), 2022. For the trial’s name and year; the figures on this page come from the Zepbound label.
- Novo Nordisk (NovoMedLink): Saxenda discontinuation notice, October 2026. Read November 1, 2026.
- Novo Nordisk: Saxenda list price. Checked November 1, 2026.
- NovoCare: Saxenda list price and savings offer. Checked November 1, 2026.
- FDA: Compounding and the FDA, questions and answers. Read November 1, 2026.
- Medicare.gov: Weight loss drugs (the Medicare
GLP-1 Bridge). Read November 1, 2026. - CMS: Medicare
GLP-1 Bridge. Read November 1, 2026. - Novo Nordisk: What to pay for Wegovy. Checked November 1, 2026.
- LillyDirect: Zepbound self-pay prices. Checked November 1, 2026.
- NexLife:
GLP-1 price index. Compounded semaglutide prices checked November 1, 2026. - NexLife: pricing, every plan.
Saxenda, Victoza, Wegovy and Ozempic are trademarks of Novo Nordisk; Zepbound, Mounjaro, Foundayo, KwikPen and LillyDirect of Eli Lilly and Company. NexLife isn’t affiliated with either, or with any generic maker named here.